ArticleIDCases2025
Severe neonatal dengue with confirmed vertical transmission of DENV-3: A fatal case from Honduras.
Article in IDCases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue virus (DENV) infection is a major public health concern, with an estimated 390 million infections annually. Although typically self-limiting, dengue can progress to severe, life-threatening complications in high-risk groups such as neonates. Vertical transmission has been reported in up to 22.7 % of pregnancies complicated by maternal dengue. We report a fatal case of severe neonatal dengue due to DENV-3, confirmed by RT-PCR in both mother and infant. The neonate, born at 38 weeks of gestation via cesarean section to a mother with severe dengue and preeclampsia with severe features, complicated by HELLP syndrome, developed hemodynamic instability and died on day 11 of life. The mother also died shortly after delivery despite intensive management. This case highlights the diagnostic and therapeutic challenges of congenital dengue, especially in resource-limited settings. The presence of DENV-3 in both mother and neonate, with fatal outcomes in both, highlights the need for early recognition, timely intensive care, and further investigation into serotype-specific risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.